A specialized independent expert commission convened by the Pan American Health Organization (PAHO) launched a week-long review on November 10, 2025, in Washington D.C., to assess whether measles has re-established sustained endemic transmission in five high-priority nations: the United States, Mexico, Guatemala, Peru, and Bolivia. The Regional Monitoring and Re-Verification Commission (RVC) is auditing full epidemiological datasets from all 35 PAHO member states, with a laser focus on jurisdictions grappling with months-long, unbroken measles outbreaks, before PAHO Director Jarbas Barbosa issues a final ruling expected in early the following week.
This review unfolds against a backdrop of a dramatic regional measles resurgence through the first 10 months of 2026, with PAHO data documenting 57,666 confirmed infections across 17 territories in the Americas, alongside 81 recorded fatalities as of October 17. Over 90% of these cases are concentrated in the five nations under heightened scrutiny, plus Canada, which became the first country in the region to lose its measles-free endemic status in November 2025. Canada’s designation loss also stripped the entire Americas region of its 2016 global recognition as the first world zone to fully eliminate endemic measles transmission, a milestone earned after decades of coordinated mass vaccination campaigns.
For the United States, the pending review carries particularly high stakes: the nation was first certified to have eliminated endemic measles spread in 2000, following years of targeted public health intervention and high vaccine uptake. The sustained outbreaks that began in early 2025 have put this decades-long achievement at severe risk. U.S. Centers for Disease Control and Prevention (CDC) data as of November 5, 2026, records 5,182 confirmed measles cases this year alone, more than double the full 2025 total of 2,289, with 43 distinct active outbreaks logged, 96% of all cases linked to ongoing community transmission. Separate Reuters tallies note nearly 7,500 total U.S. infections and 11 measles-related deaths recorded by state health authorities since the start of 2025, with discrepancies between datasets stemming from differing reporting timeframes and variable mortality tracking protocols across jurisdictions.
Crucially, raw case counts or fatality totals alone do not determine a country’s endemic status. Per PAHO formal criteria, a nation only loses its measles-free designation if a single genetically identical measles virus lineage demonstrates unbroken, continuous community transmission for a minimum of 12 consecutive months. The RVC panel is therefore evaluating a far broader set of metrics alongside case logs: viral genome sequencing data, granular contact tracing records, routine childhood measles-mumps-rubella (MMR) vaccination coverage rates, public health surveillance system performance, and the speed of local health authority response to emerging outbreak clusters.
Public health experts point to steadily declining childhood vaccination rates as the core driver of the current resurgence. CDC data shows U.S. kindergarten MMR vaccination coverage dropped to 92.4% in the 2025-2026 school year, falling below the 95% herd immunity threshold required to block widespread measles spread, an extremely contagious airborne pathogen that poses severe, life-threatening complications for young children and immunocompromised individuals.
CDC Director Erica Schwartz has emphasized that even if the U.S. loses its measles-free status, the agency will not scale back its ongoing response efforts, and will continue coordinating closely with state health departments to trace infections, isolate confirmed cases, and roll out targeted catch-up vaccination drives. A revoked endemic-free status carries no formal international sanctions, but signals a major reversal of decades of public health progress, requiring governments to allocate sustained additional funding for enhanced surveillance, contact tracing, laboratory testing, and mass immunization campaigns. Health officials note that recovery of measles-free status is achievable: Brazil lost its elimination designation in 2019, but successfully interrupted all sustained local transmission via targeted national vaccination drives, earning back its PAHO measles-free certification in 2024.
Verenigde Staten, Mexico en Guatemala riskeren verlies status mazelenvrij
